CIC ignorance consultation The latest blue book enlightenment: China's digital medical market has a wide range of services. With the advancement of technology and policy liberalization, digital medical care will go deep into medical sub-sectors and achieve rapid development.
As the world leader in emerging markets, China's healthcare industry is carrying more and more expectations. The digital diagnosis and treatment equipment is the first of the five key specialties of the “13th Five-Year†medical device, and it has been rapidly developed in the Internet+ era. Through the digitalization of medical care, the types and quantities of medical-related services using the Internet and mobile Internet platforms are rising at a high speed, greatly improving the efficiency and level of China's medical services, and helping China achieve its strategic goal of “healthy Chinaâ€. In this context, the CIC Knowledge Consulting Medical Team, which has been deeply involved in the Chinese medical industry for more than 10 years, is working together to build an industry platform to promote the innovation and development of the industry. Sinopharm Reed Exhibitions Co., Ltd. jointly launched the "2016 China Digital Medical Industry Blue Book" (hereinafter referred to as " The Blue Book" was officially released on October 29, 2016 at the 76th China International Medical Equipment Fair (CMEF).
.jpg)
Mr. Cao Shiyue, Director of Sinopharm Reed Exhibition Research Department, Mr. Li Chao, Deputy General Manager of Sinopharm Reed Exhibitions, Mr. Hou Xuchao, Founding Partner of CIC Knowledge Consulting, and Ms. Wang Wenhua, Executive Director of CIC Knowledge Consulting, launched the Blue Book Launch Ceremony
According to the Blue Book, at present, China's digital medical market has a wide range of services, covering all aspects of the industry chain, including medical device companies, pharmaceutical companies, commercial insurance companies, medical service organizations, medical workers, patients and healthy people. In terms of depth, due to the current technical limitations and policy factors in China, the digital medical industry is still far from mature in various fields. In the future, with the advancement of technology and policy liberalization, it will penetrate all aspects of medical services more deeply. The development potential is huge.
.jpg)
Mr. Hou Xuchao, Founding Partner of CIC Knowledge Consulting
Leuconostoc Mesenteroides,Leuconostoc Mesenteroide,Leuconostoc Mesenteroides Powder,Leuconostoc Mesenteroides Treatment
Jiangsu Biodep Biotechnology Co. ,Ltd. , https://www.mbioda.com